During the past decade, Holstebro Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holstebro Hospital" #1 sponsor was "Regional Hospital Holstebro" with 3 trials, followed by "Rigshospitalet, Denmark" with 3 trials sponsored, "Advanz Pharma" with 2 trials sponsored, "Anders Perner" with 1 trials sponsored and "Bavarian Nordic" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holstebro Hospital" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 1 trials as a collaborator, "Danish Heart Foundation" with 1 trials as a collaborator and "Rigshospitalet, Denmark" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Holstebro Hospital" are "Renal Failure, Chronic" (3 trials), "Anemia, Hemolytic, Autoimmune" (1 trials), "Atrial Fibrillation" (1 trials), "Atrial Fibrillation and Flutter" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Holstebro Hospital" in a lesser frequency.

Most popular intervention types in "Holstebro Hospital" are "Drug" (7 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vernakalant Injection 20 mg/mL" (2 trials), "6% Hydroxyethyl starch 130/0.4" (1 trials), "Finerenone (Kerendia, BAY94-8862)" (1 trials) and "GM-CSF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holstebro Hospital" are 12 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Holstebro Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Holstebro Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Holstebro Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".